share_log

Moderna | 144: Notice of proposed sale of securities pursuant to Rule 144

Moderna | 144: Notice of proposed sale of securities pursuant to Rule 144

Moderna | 144：拟议出售证券
美股sec公告 ·  06/11 17:43
Moomoo AI 已提取核心信息
Flagship Ventures Fund IV-Rx, L.P., an affiliate of Moderna, Inc., is set to sell 32,763 shares of Moderna's common stock, with an aggregate market value of approximately $4.86 million, on June 11, 2024. These shares were originally acquired on December 28, 2011, as part of a pre-IPO venture stage investment directly from the issuer, with cash payment. Over the past three months, Flagship Ventures has sold 200,000 shares of Moderna, generating total gross proceeds of $24.04 million.
Flagship Ventures Fund IV-Rx, L.P., an affiliate of Moderna, Inc., is set to sell 32,763 shares of Moderna's common stock, with an aggregate market value of approximately $4.86 million, on June 11, 2024. These shares were originally acquired on December 28, 2011, as part of a pre-IPO venture stage investment directly from the issuer, with cash payment. Over the past three months, Flagship Ventures has sold 200,000 shares of Moderna, generating total gross proceeds of $24.04 million.
Moderna的附属机构Flagship Ventures Fund IV-Rx, L.P.计划于2024年6月11日卖出32,763股Moderna普通股，总市值约为4,860,000美元。这些股份最初是在2011年12月28日作为风险投资的一部分直接从发行方以现金支付方式获得的。过去三个月，Flagship Ventures已出售了200,000股Moderna股票，共获得净收益2,404万美元。
Moderna的附属机构Flagship Ventures Fund IV-Rx, L.P.计划于2024年6月11日卖出32,763股Moderna普通股，总市值约为4,860,000美元。这些股份最初是在2011年12月28日作为风险投资的一部分直接从发行方以现金支付方式获得的。过去三个月，Flagship Ventures已出售了200,000股Moderna股票，共获得净收益2,404万美元。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息